Stem Cells: Model, Target, & Therapy

google-plus2 facebook < /path> twitter blogger tumblr2 reddit linkedin delicious stumbleupon mail

Tuesday, 23 June 2020

Stem cells can drive clinical development in a diversity of ways. Stem cells can help identify new therapeutics through disease modeling, drug screening, and personalized medicine. Endogenous stem cells can be the targets of therapeutics, which can stimulate regeneration in vivo. Finally, stem cells or stem cell-derived products can be the therapeutic themselves, delivered to patients to replace or repair damaged tissues. The ISSCR’s Workshop on Clinical Translation will showcase speakers from academia and industry who will discuss various approaches to develop cellular therapies in this translationally-focused program. This year’s workshop explores the broad ways that stem cells are advancing pre-clinical research and clinical trials in three sessions:

  • Modeling Stem Cells for Discovery
  • Endogenous Stem Cells as Targets
  • Stem Cells as Drugs in Clinical Trials

The Workshop on Clinical Translation is a full-day program hosted at the Boston Convention and Exhibition Center. A renowned panel of speakers will cover a range of topics from pre-clinical modeling to ongoing clinical trials. 

Date:    23 June, 2020
Time:    09:00-17:10
Where: Boston Convention and Exhibition Center

Registration: Tuesday, 25 June 07:30-09:00; Boston Convention and Exhibition Center, North Lobby

Price : $205 (trainee members), $225 (full/affiliate members), $245 (nonmembers). All prices in USD.

WCT400x266

Workshop Program

Time

Session

07:30 – 09:00Registration with coffee and tea
09:00 – 09:10

Welcome and opening remarks: Lee Rubin, Harvard University, USA

SESSION I         Modeling Stem Cells for Discovery
Moderator: Ricardo Dolmetsch, Novartis, USA
09:10 – 09:40Speaker 1 Giorgia Quadrato, University of Southern California, Keck School of Medicine, USA
09:40 – 10:10

Speaker 2 Clifford Woolf, Boston Children's Hospital, USA

10:10 – 10:40Speaker 3 Ajamete Kaykas, Insitro, USA
10:40 – 11:10Modeling Stem Cells for Discovery Panel Discussion
11:20 – 12:25Lunch
SESSION 2Endogenous Stem Cells as Targets
Moderator: Chee-Yeun Chung, Yumanity, USA
12:30 – 13:00Speaker 1 Magdalena Goetz, Helmholtz Zentrum Muenchen, Germany

 

Time

Session

13:00 – 13:30Speaker 2 TBD
13:30 – 14:00Speaker 3 Albert Edge, Massachusetts Eye and Ear; Decibel Therapeutics, USA
14:00 – 14:30Endogenous Stem Cells as Targets Panel Discussion
14:30 – 15:00Coffee break
SESSION 3Stem Cells as Drugs in Clinical Trials
Moderator: Jerry Ritz, Dana Farber Cancer Institute, USA
15:00 – 15:30Speaker 1 David Williams, Boston Children’s Hospital, USA
15:30 – 16:00Speaker 2 Agnete Kirkeby, University of Copenhagen, Denmark
16:00 – 16:30Speaker 3 TBD
16:30 – 17:00Stem Cells as Drugs Panel Discussion
17:00 – 17:10Closing Remarks: Stacie Weninger, F-Prime Capital, USA

Who Should Attend?

This program is designed for scientists, physicians, physician-scientists, and those interested in the latest clinical applications of stem cell research.

How to Register

You may register for the Workshop only or in conjunction with the ISSCR 2020 Annual Meeting. If you have already registered for ISSCR 2020 you may modify your registration to add the Workshop. Registration will be offered onsite only if there is space available. Seating is limited, however, and registration will close early if all seats are sold. Register early to reserve your spot!

Cancellations

Until 08 May, 2020 
Please email a cancellation notice to: isscr@isscr.org to request a refund of the Workshop on Clinical Translation (minus a $50 USD cancellation fee).

After 08 May, 2020
No refunds will be granted.